Late-onset pneumocystis pneumonia after kidney transplantation: A systematic review and meta-analysis of prevalence, risk factors, and outcomes

医学 肺孢子虫肺炎 肺炎 皮质类固醇 重症监护医学 肾 卡氏肺孢子虫 内科学 梅德林 人类免疫缺陷病毒(HIV) 肾移植 风险评估
作者
Sirihatai Konwai,Chanyanuch Rakpithayanon,Thunyatorn Wuttiputhanun,Asada Leelahavanichkul,Natavudh Townamchai,Jakapat Vanichanan,Kamonwan Jutivorakool,Yingyos Avihingsanon,Kearkiat Praditpornsilpa,Suwasin Udomkarnjananun
出处
期刊:Transplantation Reviews [Elsevier BV]
卷期号:40 (1): 100972-100972 被引量:7
标识
DOI:10.1016/j.trre.2025.100972
摘要

Late-onset Pneumocystis jirovecii pneumonia (PCP) is increasingly recognized in kidney transplant recipients (KTRs) despite widespread prophylaxis. However, its prevalence and risk factors remain unclear. We systematically searched electronic databases for studies published up to May 1, 2025, that reported prevalence or risk factors of late-onset PCP. Pooled prevalence, weighted mean differences (WMDs), and pooled odds ratios (ORs) were synthesized using a random-effects model. Of 1448 studies screened, 24 met inclusion criteria, comprising 57,662 KTRs, of whom 556 developed late-onset PCP. The pooled prevalence was 1.28 % (95 %CI 0.90–1.65). Lymphocyte counts were significantly lower in the infection group (WMD –408.34 cells/μL; 95 %CI –706.03 to −110.66). Risk was significantly increased with ABO-incompatible transplantation (OR 4.12; 95 %CI 1.04–16.30), rituximab induction (OR 4.77; 95 %CI, 1.50–15.21), corticosteroid (OR 2.56; 95 %CI 1.00–6.52) or mammalian target of rapamycin inhibitor (mTORi) maintenance (OR 2.37; 95 %CI 1.27–4.42), CMV infection (OR 5.21; 95 %CI 2.45–11.10), and rejection episodes (OR 2.93; 95 %CI 1.72–4.99), particularly when treated with plasma exchange, intravenous methylprednisolone, or rituximab. In contrast, cotrimoxazole prophylaxis reduced risk (OR 0.06; 95 %CI 0.01–0.60). Late-onset PCP was associated with graft loss (OR 6.11; 95 %CI 2.98–12.55) and mortality (OR 10.48; 95 %CI 1.92–57.16). Although uncommon, late-onset PCP in KTRs is strongly linked with ABO-incompatible transplantation, lack of cotrimoxazole prophylaxis, lymphopenia, CMV infection, corticosteroid and mTORi, and rejection. KTRs with these high-risk features, including those receiving mTORi and corticosteroid maintenance, should be considered for prolonged or life-long PCP prophylaxis. • The pooled prevalence of late-onset PCP infection in KTRs was 1.28 %. • Late-onset PCP was associated with increased risks of graft loss and mortality, indicating that this complication remains clinically relevant despite prophylaxis • Associated factors included ABO-incompatible transplantation, rituximab induction, maintenance therapy with corticosteroids or mTORi, lymphopenia, prior rejection and its treatment, and CMV infection. • Prolonged cotrimoxazole prophylaxis should be considered for high-risk kidney transplant recipients, particularly those with a prior history of CMV infection or receiving mTORi or corticosteroid therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
2秒前
健康的魔镜完成签到 ,获得积分10
4秒前
华无剑的应助被DW采纳,获得10
4秒前
5秒前
小乐乐完成签到 ,获得积分10
5秒前
斯文败类的应助被淡淡青枫采纳,获得10
7秒前
8秒前
山海不远发布了新的文献求助10
9秒前
uniphoton完成签到,获得积分10
10秒前
fatal发布了新的文献求助10
12秒前
111发布了新的文献求助10
12秒前
粥粥粥完成签到 ,获得积分10
13秒前
ding的应助被木木采纳,获得10
14秒前
叶上初阳完成签到,获得积分0
14秒前
干咸鱼叔叔完成签到,获得积分10
15秒前
GoGoGo完成签到,获得积分10
16秒前
hitech的应助被fatal采纳,获得10
18秒前
科研通AI6.2的应助被山海不远采纳,获得30
19秒前
含蓄书桃完成签到 ,获得积分10
19秒前
spark发布了新的文献求助10
20秒前
Crazy鑫完成签到,获得积分10
22秒前
23秒前
24秒前
快乐鼠完成签到,获得积分10
26秒前
27秒前
27秒前
WLLLR发布了新的文献求助10
27秒前
桓某人发布了新的文献求助10
28秒前
30秒前
choin6688_完成签到 ,获得积分10
31秒前
lyj发布了新的文献求助10
31秒前
眼睛大泥猴桃完成签到,获得积分10
31秒前
隐形曼青的应助被乐乐采纳,获得10
32秒前
解洙完成签到 ,获得积分10
32秒前
33秒前
王小聪明发布了新的文献求助10
34秒前
wg发布了新的文献求助10
34秒前
chongtse发布了新的文献求助10
34秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188339
求助须知:如何正确求助?哪些是违规求助? 9576127
关于积分的说明 21845709
捐赠科研通 7786389
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559588
邀请新用户注册赠送积分活动 2482196